Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapy.
Roddy
Thomas P
TP
Clinical Laboratory Science, Genzyme Corporation, One Mountain Road, Framingham, MA 01701-9322, USA.
Nelson
Bryant C
BC
Sung
Crystal C C
CC
Araghi
Shaparak
S
Wilkens
Dennis
D
Zhang
X Kate
XK
Thomas
John J
JJ
Richards
Susan M
SM
D002853:Chromatography, Liquid; D000795:Fabry Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000627:therapeutic use*; D008297:Male; D013058:Mass Spectrometry; D008991:Monitoring, Physiologic; D014281:Trihexosylceramides / Q000097:blood*; D000519:alpha-Galactosidase / Q000627:therapeutic use*
D007527:Isoenzymes; D014281:Trihexosylceramides; C018549:globotriaosylceramide; D000519:alpha-Galactosidase; C459420:agalsidase beta